Our study showed clinically relevant increases in BMIs in NPR2 carriers, although further investigation, including measures of body fat, should be conducted to clarify the role of NPR2 variants in obesity risk. This evidence concerns the gene NPR2 and obesity due to melanocortin 4 receptor deficiency.